OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Toxic Friend: Genotoxic and Mutagenic Activity of the Probiotic Strain Escherichia coli Nissle 1917
Jean‐Philippe Nougayrède, Camille V. Chagneau, Jean‐Paul Motta, et al.
mSphere (2021) Vol. 6, Iss. 4
Open Access | Times Cited: 62

Showing 26-50 of 62 citing articles:

High-quality genome-scale metabolic network reconstruction of probiotic bacterium Escherichia coli Nissle 1917
Max van ‘t Hof, Omkar S. Mohite, Jonathan M. Monk, et al.
BMC Bioinformatics (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 13

Robust performance of a live bacterial therapeutic chassis lacking the colibactin gene cluster
Aida Kalantari, Michael J. James, Lauren Renaud, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0280499-e0280499
Open Access | Times Cited: 7

Sensitive delivery systems and novel encapsulation technologies for live biotherapeutic products and probiotics
Shuang Li, Yi-Xuan Zhang
Critical Reviews in Microbiology (2023) Vol. 50, Iss. 3, pp. 371-384
Closed Access | Times Cited: 6

Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review
Sarath Gopalan, Sridhar Ganapathy, Monjori Mitra, et al.
Cureus (2023)
Open Access | Times Cited: 6

Recent advances in the use of bacterial probiotics in animal production
Alberto Gonçalves Evangelista, Jessica Audrey Feijó Corrêa, Anne Caroline Schoch Marques Pinto, et al.
Animal Health Research Reviews (2023), pp. 1-13
Closed Access | Times Cited: 6

Evaluation of Human Performance Aiding Live Synthetically Engineered Bacteria in a Gut-on-a-Chip
Mark Nelson, Heidi G. Coia, Corey C. Holt, et al.
ACS Biomaterials Science & Engineering (2022) Vol. 9, Iss. 9, pp. 5136-5150
Closed Access | Times Cited: 11

Pretreatment with IPA ameliorates colitis in mice: Colon transcriptome and fecal 16S amplicon profiling
Yawei Fu, Hu Gao, Xiaohong Hou, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10

Engineering a novel probiotic toolkit in Escherichia coli Nissle1917 for sensing and mitigating gut inflammatory diseases
Nathalie Weibel, Martina Curcio, Atilla Schreiber, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Genetic heterogeneity of engineered Escherichia coli Nissle 1917 strains during scale-up simulation
Lara Pauline Munkler, Elsayed T. Mohamed, Ruben Vazquez-Uribe, et al.
Metabolic Engineering (2024) Vol. 85, pp. 159-166
Closed Access | Times Cited: 1

Engineering a Novel Probiotic Toolkit in Escherichia coli Nissle 1917 for Sensing and Mitigating Gut Inflammatory Diseases
Nathalie Weibel, Martina Curcio, Atilla Schreiber, et al.
ACS Synthetic Biology (2024) Vol. 13, Iss. 8, pp. 2376-2390
Open Access | Times Cited: 1

Geographical variation in the incidence of colorectal cancer and urinary tract cancer is associated with population exposure to colibactin-producing Escherichia coli
Tommi Mäklin, Aurora Taira, Sergio Arredondo-Alonso, et al.
The Lancet Microbe (2024), pp. 101015-101015
Closed Access | Times Cited: 1

Therapy Used to Promote Disease Remission Targeting Gut Dysbiosis, in UC Patients with Active Disease
Hengameh Chloé Mirsepasi-Lauridsen
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7472-7472
Open Access | Times Cited: 8

Colibactin-induced genotoxicity and colorectal cancer exacerbation critically depends on adhesin-mediated epithelial binding
Maude Jans, Magdalena Kolata, Gillian Blancke, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3

Mutators drive evolution of multi-resistance to antibiotics
Danna R. Gifford, Ernesto Berríos-Caro, Christine Joerres, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 8

The Role of Cyclomodulins and Some Microbial Metabolites in Bacterial Microecology and Macroorganism Carcinogenesis
Н. Н. Маркелова, Е. Ф. Семенова, О. Н. Синева, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11706-11706
Open Access | Times Cited: 5

Molecular and Genetic Characterization of Colicinogenic Escherichia coli Strains Active against Shiga Toxin-Producing Escherichia coli O157:H7
Mauro García, María Julia Ruiz, L.M. Medina, et al.
Foods (2023) Vol. 12, Iss. 14, pp. 2676-2676
Open Access | Times Cited: 2

Towards Understanding Tumour Colonisation by Probiotic Bacterium E. coli Nissle 1917
Georgette Radford, Laura Vrbanac, Rebekah T. de Nys, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 2971-2971
Open Access

Contribution of PKS+ Escherichia coli to Colon Carcinogenesis through the inhibition of exosomal miR-885-5p
Xiaoming He, Enbo Ren, Lujia Dong, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37346-e37346
Open Access

Glucosinolates and Indole-3-carbinol from Brassica oleracea L. as inhibitors of E. coli CdtB: insights from molecular docking, dynamics, DFT and in vitro assay
Faria Tasnim, Md. Eram Hosen, Md. Enamul Haque, et al.
In Silico Pharmacology (2024) Vol. 12, Iss. 2
Closed Access

Sticky situation: how adhesive bacteria drive colon cancer
Kyanna S. Ouyang, Jens Puschhof
Nature (2024) Vol. 635, Iss. 8038, pp. 298-299
Closed Access

Non-lactic Acid Bacteria and Other Novel Probiotics
Birbal Singh, Gorakh Mal, Rajkumar Singh Kalra, et al.
(2024), pp. 141-158
Closed Access

Exploring the Impact of Probiotic Route of Administration on Its Protective Effects against Pathogenic Infection inGalleria mellonella
Lakshmi Naga Kavya Menta, Soffi Kei Kei Law, Hock Siew Tan
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Mucosal adjuvanticity and mucosal booster effect of colibactin-depleted probiotic Escherichia coli membrane vesicles
Hiroki Uchiyama, Toshifumi Kudo, Takehiro Yamaguchi, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access

Scroll to top